Clinical Trials Browser

Active not recruiting × balstilimab × 30 days × Clear all

Oropharyngeal Neoplasms

NCT03860272 2026-03-30

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

GastrointestinalGenitourinaryGynecologicSarcomaThoracic

Fibrolamellar hepatocellular carcinoma, Carcinoma, Non-Small-Cell Lung, Hemangiosarcoma, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Clinical Trials

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer